About MEVAC
MEVAC is a Healthcare company based in Cairo (Egypt) founded in 2007, and was acquired by Kemin in April 2021. Vaccines for livestock, fish, and poultry diseases are developed. MEVAC offers products and services including Poultry Vaccines, Ruminants Vaccines, Aquaculture Vaccines, Equine Vaccines, and Rabbits Vaccines. Its focus areas include HealthTech, Veterinary HealthTech, Biopharmaceuticals and Diversified. Its legal entity is MEVAC For Vaccines.
Company details
MEVAC was established in 2007 in Cairo, Egypt, within the veterinary biotechnology sector. Inactivated and live-attenuated vaccines are produced for poultry, rabbits, equine, ruminants, and aquatic species to address viral and bacterial infections. Additional services, including sample collection, diagnostic testing, and vaccination tools such as sprays and injectors, are offered to support animal health management in these areas.
Products & Services of MEVAC
MEVAC offers a comprehensive portfolio of products and services, including Poultry Vaccines, Ruminants Vaccines, Aquaculture Vaccines, Equine Vaccines, and Rabbits Vaccines.
Vaccines for protecting poultry from diseases like avian influenza
Vaccines for safeguarding ruminants against various health threats
Vaccines designed to protect fish in aquaculture settings
Vaccines for equine health and disease prevention
Vaccines to address rabbit health issues
Apps and channels of MEVAC
its YouTube channel MEVAC for Vaccines - ميفاك has 637 subscribers and 30 videos.
Videos from MEVAC
The most watched videos on MEVAC's YouTube channel, MEVAC for Vaccines - ميفاك (637 subscribers). Click a video to play it here.
More on MEVAC for Vaccines - ميفاك.
Investors in MEVAC
MEVAC has secured backing from 1 investor. Prominent investors backing the company include Kemin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Animal feed additives and specialty food ingredients are developed. | 1961 | kemin.com | Des Moines, United States |
Investor details for MEVAC
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of MEVAC
2 dated milestones of MEVAC across 14 years, from founding to its latest funding, stage changes and deals.
- Founded MEVAC is founded.
- Exit Acquired by Kemin.
Web traffic of MEVAC
The website of MEVAC (me-vac.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 14.5% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mevac
Complete news archive for MEVAC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MEVAC
MEVAC was founded in 2007.
MEVAC is headquartered in Cairo, Egypt.
MEVAC was established in 2007 in Cairo, Egypt, within the veterinary biotechnology sector. Inactivated and live-attenuated vaccines are produced for poultry, rabbits, equine, ruminants, and aquatic species to address viral and bacterial infections. Additional services, including sample collection, diagnostic testing, and vaccination tools such as sprays and injectors, are offered to support animal health management in these areas.
MEVAC offers Poultry Vaccines, Ruminants Vaccines, Aquaculture Vaccines, Equine Vaccines, and Rabbits Vaccines.
MEVAC has 1 investor. Key investors include Kemin.
MEVAC operates through Mevac For Vaccines.
Yes. MEVAC was acquired by Kemin in April 2021.